Mendola C, Ferrante D, Oldani E, Cammarota G, Cecci G, Vaschetto R, Della Corte F
Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, University of Eastern Piedmont A. Avogadro, Corso Mazzini 18, 28100 Novara, Italy.
Br J Anaesth. 2009 Mar;102(3):418-23. doi: 10.1093/bja/aep004. Epub 2009 Feb 3.
Relative effects of dosage, volume and concentration of local anaesthetics used for postoperative thoracic epidural analgesia are still under debate. In this randomized, prospective, double-blinded study, we evaluated the incidence of side-effects such as changes in arterial pressure, postoperative nausea, vomiting, and pruritus in patients admitted for thoracic surgery during continuous thoracic epidural infusion using levobupivacaine and sufentanil mixture in three different volumes.
We studied 150 patients who underwent thoracotomy with a thoracic epidural catheter placed between T4 and T7. The patients were randomized into three groups which received 10 mg h(-1) of levobupivacaine at three different concentrations (0.5%, 0.25%, and 0.15%), in combination with sufentanil at 2.6 microg h(-1). Haemodynamic effects, pruritus, nausea, vomiting, sensory and motor block, pain score, additional analgesic requirement, sedation, and patient satisfaction were registered immediately after the surgical operation and on the first, second, and third postoperative days.
We did not detect any differences in the incidence of side-effects such as changes in arterial pressure, and also postoperative nausea, vomiting, and pruritus. The three groups were also similar with regard to patient characteristics, sensory and motor block, pain score, analgesic rescue dose, sedation, and patient satisfaction.
The same dose of a mixture of levobupivacaine and sufentanil administered in three different volumes and concentrations during continuous thoracic epidural infusion for thoracotomy provided an equal incidence of adverse haemodynamic effects, nausea, vomiting, or pruritus.
用于术后胸段硬膜外镇痛的局部麻醉药的剂量、容量和浓度的相对效应仍存在争议。在这项随机、前瞻性、双盲研究中,我们评估了在胸段手术患者连续胸段硬膜外输注三种不同容量的左旋布比卡因和舒芬太尼混合液期间,诸如动脉压变化、术后恶心、呕吐和瘙痒等副作用的发生率。
我们研究了150例行开胸手术且胸段硬膜外置管于T4至T7之间的患者。患者被随机分为三组,分别接受三种不同浓度(0.5%、0.25%和0.15%)的10 mg h⁻¹左旋布比卡因,并联合2.6 μg h⁻¹舒芬太尼。在手术结束后以及术后第1、2和3天记录血流动力学效应、瘙痒、恶心、呕吐、感觉和运动阻滞、疼痛评分、额外镇痛需求、镇静情况以及患者满意度。
我们未发现诸如动脉压变化以及术后恶心、呕吐和瘙痒等副作用发生率的任何差异。三组在患者特征、感觉和运动阻滞、疼痛评分、镇痛补救剂量、镇静情况以及患者满意度方面也相似。
在开胸手术连续胸段硬膜外输注期间,以三种不同容量和浓度给予相同剂量的左旋布比卡因和舒芬太尼混合液,产生不良血流动力学效应、恶心、呕吐或瘙痒的发生率相同。